These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8591970)

  • 1. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors for children and adolescents.
    Kastelic EA; Labellarte MJ; Riddle MA
    Curr Psychiatry Rep; 2000 Apr; 2(2):117-23. PubMed ID: 11122943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].
    Ebert D
    Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
    Prescrire Int; 2004 Oct; 13(73):163-5. PubMed ID: 15499694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review.
    Sharp SC; Hellings JA
    Clin Drug Investig; 2006; 26(5):247-55. PubMed ID: 17163258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Brignell A; Randall M; Silove N; Hazell P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.